247 related articles for article (PubMed ID: 25379530)
1. Solid tumor-targeting theranostic polymer nanoparticle in nuclear medicinal fields.
Makino A; Kimura S
ScientificWorldJournal; 2014; 2014():424513. PubMed ID: 25379530
[TBL] [Abstract][Full Text] [Related]
2. [Polymer nanoparticles for the delivery of anticancer drug].
Nicolas J; Couvreur P
Med Sci (Paris); 2017 Jan; 33(1):11-17. PubMed ID: 28120750
[TBL] [Abstract][Full Text] [Related]
3. Ultrasmall Hyperbranched Semiconducting Polymer Nanoparticles with Different Radioisotopes Labeling for Cancer Theranostics.
Yi X; Xu M; Zhou H; Xiong S; Qian R; Chai Z; Zhao L; Yang K
ACS Nano; 2018 Sep; 12(9):9142-9151. PubMed ID: 30180555
[TBL] [Abstract][Full Text] [Related]
4. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
5. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
6. Radiolabeled Dendrimers for Nuclear Medicine Applications.
Zhao L; Zhu M; Li Y; Xing Y; Zhao J
Molecules; 2017 Aug; 22(9):. PubMed ID: 28841180
[TBL] [Abstract][Full Text] [Related]
7. Supramolecular nanoscale assemblies for cancer diagnosis and therapy.
Coelho SC; Pereira MC; Juzeniene A; Juzenas P; Coelho MAN
J Control Release; 2015 Sep; 213():152-167. PubMed ID: 26160308
[TBL] [Abstract][Full Text] [Related]
8. Theranostic and nanotheranostic probes in nuclear medicine.
Drude N; Tienken L; Mottaghy FM
Methods; 2017 Nov; 130():14-22. PubMed ID: 28698069
[TBL] [Abstract][Full Text] [Related]
9. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
Bayram B; Ozgur A; Tutar L; Tutar Y
Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
[TBL] [Abstract][Full Text] [Related]
10. Radioactive polymeric nanoparticles for biomedical application.
Wu S; Helal-Neto E; Matos APDS; Jafari A; Kozempel J; Silva YJA; Serrano-Larrea C; Alves Junior S; Ricci-Junior E; Alexis F; Santos-Oliveira R
Drug Deliv; 2020 Dec; 27(1):1544-1561. PubMed ID: 33118416
[TBL] [Abstract][Full Text] [Related]
11. Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis.
Luk BT; Zhang L
ACS Appl Mater Interfaces; 2014 Dec; 6(24):21859-73. PubMed ID: 25014486
[TBL] [Abstract][Full Text] [Related]
12. Constructing aptamer anchored nanovesicles for enhanced tumor penetration and cellular uptake of water soluble chemotherapeutics.
Li X; Zhu X; Qiu L
Acta Biomater; 2016 Apr; 35():269-79. PubMed ID: 26873366
[TBL] [Abstract][Full Text] [Related]
13. Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.
Yu DH; Lu Q; Xie J; Fang C; Chen HZ
Biomaterials; 2010 Mar; 31(8):2278-92. PubMed ID: 20053444
[TBL] [Abstract][Full Text] [Related]
14. Targeted nanoparticles assembled via complexation of boronic-acid-containing targeting moieties to diol-containing polymers.
Han H; Davis ME
Bioconjug Chem; 2013 Apr; 24(4):669-77. PubMed ID: 23461746
[TBL] [Abstract][Full Text] [Related]
15. Lipid-coated polymeric nanoparticles for cancer drug delivery.
Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
[TBL] [Abstract][Full Text] [Related]
16. Supramolecular Self-Assembled Nanogels a New Platform for Anticancer Drug Delivery.
Varshosaz J; Taymouri S; Ghassami E
Curr Pharm Des; 2017; 23(35):5242-5260. PubMed ID: 28699536
[TBL] [Abstract][Full Text] [Related]
17. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface Engineering.
Tran TT; Tran PH; Wang Y; Li P; Kong L
Curr Pharm Des; 2016; 22(19):2904-12. PubMed ID: 26898738
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral drug delivery with nanoparticulate carriers.
Holback H; Yeo Y
Pharm Res; 2011 Aug; 28(8):1819-30. PubMed ID: 21213021
[TBL] [Abstract][Full Text] [Related]
20. Towards the use of nanoparticles in cancer therapy and imaging.
Pauwels EK; Erba P
Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
